Starpharma Holdings Limited

SPHRF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$4,598-$5,392-$7,131-$1,034
Dep. & Amort.$531$539$546$569
Deferred Tax$0$0$0$0
Stock-Based Comp.$871$0$1,466$0
Change in WC$2,442$0$2,230$0
Other Non-Cash-$4,009$2,857-$6,186$2,563
Operating Cash Flow-$4,763-$1,996-$9,075$2,098
Investing Activities
PP&E Inv.-$11-$31-$80-$9
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$11-$31-$80-$9
Financing Activities
Debt Repay.$0-$1,050$0-$5,143
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$78$0$396$0
Financing Cash Flow-$78-$1,050$396-$5,143
Forex Effect-$18-$6-$12$3
Net Chg. in Cash-$20,277$20,277-$8,771-$3,049
Supplemental Information
Beg. Cash$20,277$0$32,131$35,180
End Cash$0$20,277$23,360$32,131
Free Cash Flow-$4,774-$2,027-$9,155$2,089